TCL Archive NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile November 30, 2012
TCL Archive NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel October 17, 1980
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
